Safety of epoietin beta-quinine drug combination in children with cerebral malaria in Mali
暂无分享,去创建一个
O. Doumbo | A. Djimde | A. Bienvenu | S. Picot | Abdoulaye Barry | Sibiri Sissoko | S. Konaté | Elizabeth Diarra | Karidiatou Bamba
[1] M. Chopp,et al. Neurorestorative treatment of stroke: Cell and pharmacological approaches , 2006, NeuroRX.
[2] M. Mathru. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial , 2010 .
[3] J. Pickard,et al. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article. , 2009, Journal of neurosurgery.
[4] T. Taylor. Caring for children with cerebral malaria: insights gleaned from 20 years on a research ward in Malawi. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[5] C. Newton,et al. Can erythropoietin be used to prevent brain damage in cerebral malaria? , 2009, Trends in parasitology.
[6] M. Eisenhut,et al. Artemisinin derivatives versus quinine in treating severe malaria in children: a systematic review , 2008, Malaria Journal.
[7] Stéphane Picot,et al. Artesunate-erythropoietin combination for murine cerebral malaria treatment. , 2008, Acta tropica.
[8] S. Ranque,et al. Life-Threatening Malaria in African Children: A Prospective Study in a Mesoendemic Urban Setting , 2008, The Pediatric infectious disease journal.
[9] N. Day,et al. The management of patients with severe malaria. , 2007, The American journal of tropical medicine and hygiene.
[10] J. Tumwine,et al. Mannitol as adjunct therapy for childhood cerebral malaria in Uganda: A randomized clinical trial , 2007, Malaria Journal.
[11] B. Neville,et al. Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children. , 2007, JAMA.
[12] A. Cerami,et al. Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. , 2006, Kidney international.
[13] D. Kwiatkowski,et al. Standardized data collection for multi-center clinical studies of severe malaria in African children: establishing the SMAC network. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[14] J. Golenser,et al. Conventional and experimental treatment of cerebral malaria. , 2006, International journal for parasitology.
[15] A. Buguet,et al. Recombinant human erythropoietin prevents the death of mice during cerebral malaria. , 2006, The Journal of infectious diseases.
[16] G. Enwere. A review of the quality of randomized clinical trials of adjunctive therapy for the treatment of cerebral malaria , 2005, Tropical medicine & international health : TM & IH.
[17] Arjen Dondorp,et al. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial , 2005, The Lancet.
[18] A. Cerami,et al. Emerging biological roles for erythropoietin in the nervous system , 2005, Nature Reviews Neuroscience.
[19] K. Maiese,et al. Erythropoietin on a Tightrope: Balancing Neuronal and Vascular Protection between Intrinsic and Extrinsic Pathways , 2004, Neurosignals.
[20] M. Herrmann,et al. Erythropoietin: Novel Approaches to Neuroprotection in Human Brain Disease , 2004, Metabolic Brain Disease.
[21] P. Ghezzi,et al. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[22] P. Ghezzi,et al. Erythropoietin as an antiapoptotic, tissue-protective cytokine , 2004, Cell Death and Differentiation.
[23] M. Rosenzweig,et al. The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events. , 2004, Journal of pain and symptom management.
[24] M. Omata,et al. Blood pressure response to erythropoietin injection in hemodialysis and predialysis patients. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.
[25] P. Ghezzi,et al. Erythropoietin Selectively Attenuates Cytokine Production and Inflammation in Cerebral Ischemia by Targeting Neuronal Apoptosis , 2003, The Journal of experimental medicine.
[26] M. Buemi,et al. The Pleiotropic Effects of Erythropoietin in the Central Nervous System , 2003, Journal of neuropathology and experimental neurology.
[27] P. Lewczuk,et al. Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial , 2002, Molecular medicine.
[28] Stuart A. Lipton,et al. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades , 2001, Nature.
[29] P. Lewczuk,et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] Charles R. Newton,et al. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. , 1998, Pharmacology & therapeutics.
[31] D. Parry,et al. Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[32] B. Rafferty,et al. Epoetin alfa and beta differ in their erythropoietin isoform compositions and biological properties. , 1998, British journal of haematology.
[33] D. Kwiatkowski,et al. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. , 1996, The Journal of infectious diseases.
[34] R. Snow,et al. Indicators of life-threatening malaria in African children. , 1995, The New England journal of medicine.
[35] R. Micciolo,et al. Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. , 1995, The Journal of infectious diseases.
[36] M. Fukuda,et al. Survival of recombinant erythropoietin in the circulation: the role of carbohydrates. , 1989, Blood.
[37] D. Warrell,et al. Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. , 1982, The New England journal of medicine.